Filing Details
- Accession Number:
- 0001209191-21-049758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 18:29:42
- Reporting Period:
- 2021-08-02
- Accepted Time:
- 2021-08-04 18:29:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1828443 | Ortho Clinical Diagnostics Holdings Plc | OCDX | In Vitro & In Vivo Diagnostic Substances (2835) | 981151819 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1841149 | Clifton Robert Yates | C/O Ortho Clinical Diagnostics Holdings 1001 Route 202 Raritan NJ 08869 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.00001 Par Value | Acquisiton | 2021-08-02 | 23,062 | $6.28 | 346,942 | No | 4 | M | Direct | |
| Ordinary Shares, $0.00001 Par Value | Disposition | 2021-08-02 | 25,551 | $22.06 | 321,391 | No | 4 | S | Direct | |
| Ordinary Shares, $0.00001 Par Value | Disposition | 2021-08-03 | 176,149 | $21.59 | 145,242 | No | 4 | S | Direct | |
| Ordinary Shares, $0.00001 Par Value | Disposition | 2021-08-04 | 140,042 | $21.79 | 5,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.00001 Par Value | Stock Option | Disposition | 2021-08-02 | 23,062 | $0.00 | 23,062 | $6.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,025,225 | 2024-10-22 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
- Represents the weighted average sales price for the price increments ranging from $21.65 to $22.51.
- Represents the weighted average sales price for the price increments ranging from $21.18 to $21.94.
- Represents the weighted average sales price for the price increments ranging from $21.51 to $21.92.
- The stock option is fully vested and exercisable.
Billionaire Hedge Funds
